Literature DB >> 20658237

Renal involvement in childhood-onset systemic lupus erythematosus in Egypt.

Samia Salah-El-Din Mahmoud1, Hafez Mahmoud Bazaraa, Hala Mohamed Lotfy, Doaa Mohamed Abd-El-Aziz.   

Abstract

Lupus nephritis has been described as the most serious complication of systemic lupus erythematosus (SLE) and the strongest predictor of poor outcome. While the incidence of childhood SLE is relatively low, renal involvement appears to be more common and more severe in childhood SLE. This study aims to characterize the features and outcome of renal involvement in childhood-onset SLE based on a study of 100 Egyptian patients (mean age at diagnosis 10.1 years, range 2-17 years). Initial data regarding disease manifestations and biopsy findings were reviewed. Disease activity was assessed using SLEDAI scores. Follow-up data (mean duration 6 years) were noted regarding specific treatment, response, complications and renal survival. Initial renal involvement was present in 78 patients, including 66 with hypertension and 23 with renal impairment. Pathologically, class IV nephropathy was found in 18 patients, class V in 9 and low-grade lesions (class II-III) in 49. Twenty patients required follow-up biopsy, and all transformations were observed. SLEDAI scores significantly decreased from initial (mean ± SD) of 21.4 ± 7.3 to 13.4 ± 7.8, in association with response to therapy (P < 0.0001). Poor response was associated with initial hypertension and renal impairment but not with initial SLEDAI score or pathological class. The projected renal survival was 82.4 and 64.7% 5 and 10 years from diagnosis. Early renal involvement in childhood SLE is common, serious and requires proper evaluation and management.

Entities:  

Mesh:

Year:  2010        PMID: 20658237     DOI: 10.1007/s00296-010-1554-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Lupus nephritis in children: prognostic significance of clinicopathological findings.

Authors:  S Emre; I Bilge; A Sirin; I Kilicaslan; A Nayir; F Oktem; V Uysal
Journal:  Nephron       Date:  2001-02       Impact factor: 2.847

Review 2.  Treatment of lupus nephritis in children.

Authors:  P Niaudet
Journal:  Pediatr Nephrol       Date:  2000-02       Impact factor: 3.714

3.  Lupus nephritis in Lebanon.

Authors:  I W Uthman; A A Muffarij; W A Mudawar; F W Nasr; A F Masri
Journal:  Lupus       Date:  2001       Impact factor: 2.911

4.  Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.

Authors:  Sauwalak Opastirakul; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2005-08-24       Impact factor: 3.714

5.  Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center.

Authors:  D L Huong; T Papo; H Beaufils; B Wechsler; O Blétry; A Baumelou; P Godeau; J C Piette
Journal:  Medicine (Baltimore)       Date:  1999-05       Impact factor: 1.889

6.  Diversity in presenting manifestations of systemic lupus erythematosus in children.

Authors:  S Iqbal; M R Sher; R A Good; G D Cawkwell
Journal:  J Pediatr       Date:  1999-10       Impact factor: 4.406

7.  Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center.

Authors:  K Neumann; D J Wallace; C Azen; S Nessim; M Fichman; A L Metzger; J R Klinenberg
Journal:  Semin Arthritis Rheum       Date:  1995-08       Impact factor: 5.532

8.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

9.  Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH.

Authors:  H C Gan; K Hyoon; K Y Fong
Journal:  Singapore Med J       Date:  2002-12       Impact factor: 1.858

10.  Lupus nephritis in children: a longitudinal study of prognostic factors and therapy.

Authors:  N Baqi; S Moazami; A Singh; H Ahmad; S Balachandra; A Tejani
Journal:  J Am Soc Nephrol       Date:  1996-06       Impact factor: 10.121

View more
  5 in total

1.  Association of c-Jun gene polymorphism with susceptibility to systemic lupus erythematosus in a Chinese population.

Authors:  Yan Ma; Jing Tian; Han Cen; Jing Li; Wang-Dong Xu; De-Guang Wang; Hai-Feng Pan; Dong-Qing Ye
Journal:  DNA Cell Biol       Date:  2012-04-10       Impact factor: 3.311

Review 2.  Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis.

Authors:  Tiffany Caza; Chathura Wijewardena; Laith Al-Rabadi; Andras Perl
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

3.  Increase in direct costs for health systems due to lupus nephritis: the case of Colombia.

Authors:  Sergio I Prada; Ana M Pérez; Ivana Nieto-Aristizábal; Gabriel J Tobón
Journal:  Einstein (Sao Paulo)       Date:  2022-04-22

4.  Lupus nephritis in Egyptian children: a 16-year experience.

Authors:  Atef Elmougy; Amr Sarhan; Ayman Hammad; Ahmed El-Refaey; Mohammed Zedan; Riham Eid; Wafaa Laimon; Wafaa Limon; Ashraf Abd Elrahman; Fatma Elhussieni; Enas El-Sherbeny; Ashraf Bakr
Journal:  J Nephrol       Date:  2014-12-10       Impact factor: 3.902

5.  Damage index in childhood-onset systemic lupus erythematosus in Egypt.

Authors:  Samia Salah; Hala M Lotfy; Abir N Mokbel; Ahmed M Kaddah; Nouran Fahmy
Journal:  Pediatr Rheumatol Online J       Date:  2011-12-09       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.